Humoral immunity to SARS-CoV-2 elicited by combination COVID-19 vaccination regimens.


Journal

The Journal of experimental medicine
ISSN: 1540-9538
Titre abrégé: J Exp Med
Pays: United States
ID NLM: 2985109R

Informations de publication

Date de publication:
03 10 2022
Historique:
received: 11 05 2022
revised: 19 06 2022
accepted: 13 07 2022
entrez: 25 8 2022
pubmed: 26 8 2022
medline: 30 8 2022
Statut: ppublish

Résumé

The SARS-CoV-2 pandemic prompted a global vaccination effort and the development of numerous COVID-19 vaccines at an unprecedented scale and pace. As a result, current COVID-19 vaccination regimens comprise diverse vaccine modalities, immunogen combinations, and dosing intervals. Here, we compare vaccine-specific antibody and memory B cell responses following two-dose mRNA, single-dose Ad26.COV.2S, and two-dose ChAdOx1, or combination ChAdOx1/mRNA vaccination. Plasma-neutralizing activity, as well as the magnitude, clonal composition, and antibody maturation of the RBD-specific memory B cell compartments, showed substantial differences between the vaccination regimens. While individual monoclonal antibodies derived from memory B cells exhibited similar binding affinities and neutralizing potency against Wuhan-Hu-1 SARS-CoV-2, there were significant differences in epitope specificity and neutralizing breadth against viral variants of concern. Although the ChAdOx1 vaccine was inferior to mRNA and Ad26.COV.2S in several respects, biochemical and structural analyses revealed enrichment in a subgroup of memory B cell neutralizing antibodies with distinct RBD-binding properties resulting in remarkable potency and breadth.

Identifiants

pubmed: 36006380
pii: 213420
doi: 10.1084/jem.20220826
pmc: PMC9418484
pii:
doi:

Substances chimiques

Antibodies, Neutralizing 0
Antibodies, Viral 0
COVID-19 Vaccines 0
RNA, Messenger 0
Viral Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Federal Institute for Drugs and Medical Devices
ID : V-2021.3/1503_68403/2021-2022
Organisme : Bulgari Women and Science Fellowship
Organisme : NCATS NIH HHS
ID : UL1 TR001866
Pays : United States
Organisme : Deutsche Forschungsgemeinschaft
Organisme : Howard Hughes Medical Institute
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI138938
Pays : United States
Organisme : Charité Universitätsmedizin Berlin
Organisme : Shapiro-Silverberg Fund for the Advancement of Translational Research
Organisme : NIAID NIH HHS
ID : R37 AI064003
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI078788
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI165075
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001866
Pays : United States

Informations de copyright

© 2022 Wang et al.

Références

Nat Immunol. 2022 Mar;23(3):380-385
pubmed: 35115679
Nature. 2021 Dec;600(7890):701-706
pubmed: 34673755
Cell. 2021 Apr 15;184(8):2183-2200.e22
pubmed: 33756110
Nat Med. 2021 Sep;27(9):1530-1535
pubmed: 34312554
Nature. 2021 Apr;592(7855):616-622
pubmed: 33567448
Methods. 2016 May 1;100:25-34
pubmed: 26931650
N Engl J Med. 2022 Mar 10;386(10):933-941
pubmed: 35020982
Nature. 2021 Jul;595(7867):426-431
pubmed: 34126625
Science. 2022 Feb 18;375(6582):782-787
pubmed: 35076281
Nat Med. 2021 Nov;27(11):2032-2040
pubmed: 34588689
Lancet Respir Med. 2021 Nov;9(11):1255-1265
pubmed: 34391547
Nature. 2020 Aug;584(7821):437-442
pubmed: 32555388
Annu Rev Med. 2022 Jan 27;73:1-16
pubmed: 34428080
Science. 2020 Aug 28;369(6507):1119-1123
pubmed: 32661058
Elife. 2020 Oct 28;9:
pubmed: 33112236
J Exp Med. 2022 Aug 1;219(8):
pubmed: 35776090
Science. 2021 Aug 13;373(6556):
pubmed: 34210892
Immunity. 2022 Jun 14;55(6):998-1012.e8
pubmed: 35447092
Immunity. 2021 Aug 10;54(8):1853-1868.e7
pubmed: 34331873
J Exp Med. 2020 Nov 2;217(11):
pubmed: 32692348
Mol Syst Biol. 2011 Oct 11;7:539
pubmed: 21988835
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Nat Med. 2020 Jul;26(7):1033-1036
pubmed: 32398876
Nat Methods. 2017 Mar;14(3):290-296
pubmed: 28165473
Science. 2022 Mar 4;375(6584):1041-1047
pubmed: 35143256
Cell. 2020 Jun 25;181(7):1489-1501.e15
pubmed: 32473127
Nature. 2021 Dec;600(7889):517-522
pubmed: 34619745
Lancet Haematol. 2022 Jan;9(1):e73-e80
pubmed: 34774202
Sci Immunol. 2022 Mar 25;7(69):eabo2202
pubmed: 35113647
Science. 2020 Sep 18;369(6510):1501-1505
pubmed: 32703906
Sci Transl Med. 2021 Jan 20;13(577):
pubmed: 33288661
Vaccine. 2022 May 11;40(22):3027-3037
pubmed: 35459558
JAMA Netw Open. 2022 Mar 1;5(3):e220868
pubmed: 35234883
Nature. 2019 Feb;566(7744):398-402
pubmed: 30760926
ACS Cent Sci. 2021 Apr 28;7(4):594-602
pubmed: 34056089
Lancet Reg Health Eur. 2021 Dec;11:100249
pubmed: 34693387
Cell. 2020 Jan 9;180(1):92-106.e11
pubmed: 31866068
Nature. 2021 Dec;600(7890):580-583
pubmed: 34916666
N Engl J Med. 2022 Feb 10;386(6):599-601
pubmed: 35030645
mBio. 2022 Aug 30;13(4):e0084022
pubmed: 35735743
Nat Hum Behav. 2021 Jul;5(7):947-953
pubmed: 33972767
Nature. 2021 Mar;591(7851):639-644
pubmed: 33461210
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Adv Virus Res. 2019;105:93-116
pubmed: 31522710
Science. 2020 Nov 20;370(6519):950-957
pubmed: 32972994
Nat Med. 2021 Jul;27(7):1205-1211
pubmed: 34002089
J Struct Biol. 2005 Oct;152(1):36-51
pubmed: 16182563
Bioinformatics. 2015 Oct 15;31(20):3356-8
pubmed: 26069265
MMWR Morb Mortal Wkly Rep. 2021 Sep 24;70(38):1337-1343
pubmed: 34555004
Cell. 2022 Jul 7;185(14):2434-2451.e17
pubmed: 35764089
Acta Crystallogr D Struct Biol. 2019 Oct 1;75(Pt 10):861-877
pubmed: 31588918
N Engl J Med. 2007 Nov 8;357(19):1903-15
pubmed: 17989383
Front Immunol. 2019 Oct 09;10:2365
pubmed: 31649674
N Engl J Med. 2021 Sep 9;385(11):1049-1051
pubmed: 34260850
Nature. 2020 Dec;588(7839):682-687
pubmed: 33045718
Lancet. 2021 Mar 6;397(10277):881-891
pubmed: 33617777
JAMA Netw Open. 2022 Jan 4;5(1):e2142725
pubmed: 35015067
PLoS One. 2016 Aug 11;11(8):e0160853
pubmed: 27513338
N Engl J Med. 2022 Jan 27;386(4):340-350
pubmed: 35021002
N Engl J Med. 2021 Oct 14;385(16):1474-1484
pubmed: 34320281
Nat Med. 2021 Sep;27(9):1525-1529
pubmed: 34262158
Protein Sci. 2018 Jan;27(1):14-25
pubmed: 28710774
Nature. 2022 Jul;607(7917):128-134
pubmed: 35447027
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508

Auteurs

Zijun Wang (Z)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.

Frauke Muecksch (F)

Laboratory of Retrovirology, The Rockefeller University, New York, NY.

Friederike Muenn (F)

Department of Infectious Diseases and Respiratory Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Alice Cho (A)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.

Shuai Zong (S)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.

Raphael Raspe (R)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.

Victor Ramos (V)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.

Brianna Johnson (B)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.

Tarek Ben Tanfous (T)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.

Justin DaSilva (J)

Laboratory of Retrovirology, The Rockefeller University, New York, NY.

Eva Bednarski (E)

Laboratory of Retrovirology, The Rockefeller University, New York, NY.

Camila Guzman-Cardozo (C)

Laboratory of Retrovirology, The Rockefeller University, New York, NY.

Martina Turroja (M)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.

Katrina G Millard (KG)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.

Pinkus Tober-Lau (P)

Department of Infectious Diseases and Respiratory Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.

David Hillus (D)

Department of Infectious Diseases and Respiratory Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Kai-Hui Yao (KH)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.

Irina Shimeliovich (I)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.

Juan Dizon (J)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.

Anna Kaczynska (A)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.

Mila Jankovic (M)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.

Anna Gazumyan (A)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.

Thiago Y Oliveira (TY)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.

Marina Caskey (M)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.

Paul D Bieniasz (PD)

Laboratory of Retrovirology, The Rockefeller University, New York, NY.
Howard Hughes Medical Institute, The Rockefeller University, New York, NY.

Theodora Hatziioannou (T)

Laboratory of Retrovirology, The Rockefeller University, New York, NY.

Florian Kurth (F)

Department of Infectious Diseases and Respiratory Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Leif Erik Sander (LE)

Department of Infectious Diseases and Respiratory Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Berlin Institute of Health (BIH), Berlin, Germany.

Michel C Nussenzweig (MC)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.
Howard Hughes Medical Institute, The Rockefeller University, New York, NY.

Christian Gaebler (C)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.
Department of Infectious Diseases and Respiratory Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH